In January 2017, Allergan Inc. agreed with the SEC that it would pay a $15 million fine for failing to disclose, in its Schedule 14D-9 response to the unsolicited tender offer for the company by Valea…
Allergan Fine Is a Reminder of the Obligation to Disclose White-Knight Negotiations Following an Unsolicited Tender Offer
This is premium content for:
ABA Business Law Section Members.
Please log in or join the Business Law Section to read this full article.
Searchable Keywords:
